These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 5710606)

  • 1. [Perphenazine enantate in long-term therapy of psychoses].
    Gunby B
    Nord Psykiatr Tidsskr; 1968; 22(4):358-60. PubMed ID: 5710606
    [No Abstract]   [Full Text] [Related]  

  • 2. Abscesses following prolonged intramuscular administration of perphenazine enantate.
    Starmark JE; Forsman A; Wahlström
    Acta Psychiatr Scand; 1980 Aug; 62(2):154-7. PubMed ID: 6110312
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical experiences with perphenazine enanthate].
    Rafter B
    Nord Psykiatr Tidsskr; 1971; 25(4):371-4. PubMed ID: 5154124
    [No Abstract]   [Full Text] [Related]  

  • 4. Dose-response relationships of perphenazine in the treatment of acute psychoses.
    Hansen LB; Larsen NE; Gulmann N
    Psychopharmacology (Berl); 1982; 78(2):112-5. PubMed ID: 6817364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adding other antipsychotics to clozapine.
    Cooke C; de Leon J
    J Clin Psychiatry; 1999 Oct; 60(10):710. PubMed ID: 10549694
    [No Abstract]   [Full Text] [Related]  

  • 6. Loxapine versus perphenazine in psychotic patients. A double-blind, randomized, multicentre trial.
    Fruensgaard K; Wollenberg J; Hansen KM; Fensbo C; Sihm F
    Curr Med Res Opin; 1978; 5(8):601-7. PubMed ID: 361345
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neuroleptic malignant syndrome during perphenazine treatment.
    Nielsen D; Aunsholt NA; Andersen PT
    Pharmacol Toxicol; 1987 Mar; 60(3):221-2. PubMed ID: 3588517
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Perphenazine concentrations in human whole blood. A pilot study during anti-psychotic therapy using different administration forms.
    Hansen CE; Larsen NE
    Psychopharmacologia; 1974 Jun; 37(1):31-6. PubMed ID: 4415024
    [No Abstract]   [Full Text] [Related]  

  • 9. Clozapine versus perphenazine: the value of the biochemical mode of action of neuroleptics in predicting their therapeutic activity.
    Van Praag HM; Korf J; Dols LC
    Br J Psychiatry; 1976 Dec; 129():547-55. PubMed ID: 1000139
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Perphenazine enanthate. Results of a 1-year open multicenter study].
    Baruch P; Brion S; Broussolle P; Gayral LF; Ropert R; Volmat R; Porot M
    Encephale; 1989; 15(5):449-55. PubMed ID: 2686965
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Perphenazine. Indications].
    Van Steenkiste J
    Psychopharmacologie; 1971; ():63-70. PubMed ID: 5162008
    [No Abstract]   [Full Text] [Related]  

  • 12. Intramuscular perphenazine for the treatment of disturbed behavior.
    Ritter RM; Jaquith WL; Nail HR; Head JJ
    J Miss State Med Assoc; 1968 Nov; 9(11):532-3. PubMed ID: 5722887
    [No Abstract]   [Full Text] [Related]  

  • 13. Plasma levels of perphenazine (Trilafon) related to development of extrapyramidal side effects.
    Hansen LB; Larsen NE; Vestergård P
    Psychopharmacology (Berl); 1981; 74(4):306-9. PubMed ID: 6794071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of antipsychotic therapy in a naturalistic setting: a comparison between risperidone, perphenazine, and haloperidol.
    Coley KC; Carter CS; DaPos SV; Maxwell R; Wilson JW; Branch RA
    J Clin Psychiatry; 1999 Dec; 60(12):850-6. PubMed ID: 10665632
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Results of treatment of schizophrenic and schizoaffective patients with sulpiride (Eglonyl Alkaloid) in comparison with perphenazine (Perfenazin Spofa)].
    Svestka J; Rysánek R; Náhunek K; Cesková E
    Cesk Psychiatr; 1990 Jun; 86(3):145-56. PubMed ID: 2225184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Zuclopenthixol and perphenazine in patients with acute psychotic states. A double-blind multicentre study.
    Remvig J; Larsen H; Rask P; Skausig OB; Skov S; Strömgren LS
    Pharmacopsychiatry; 1987 Jul; 20(4):147-54. PubMed ID: 3615572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low dose perphenazine and levodopa/carbidopa therapy in a patient with Parkinsonism and a psychotic illness.
    Hale MS; Bellizzi J
    J Nerv Ment Dis; 1980 May; 168(5):312-4. PubMed ID: 7365497
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of perphenazine in psychiatric emergencies: the concept of chemical restraint.
    Fann WE; Linton PH
    Curr Ther Res Clin Exp; 1972 Aug; 14(8):478-82. PubMed ID: 4629310
    [No Abstract]   [Full Text] [Related]  

  • 19. Perphenazine-benztropine mesylate treatment of newly admitted psychiatric patients.
    Hanlon TE; Schoenrich C; Freinek W; Turek I; Kurland AA
    Psychopharmacologia; 1966; 9(4):328-39. PubMed ID: 4874349
    [No Abstract]   [Full Text] [Related]  

  • 20. [Technic and role of neuroleptic treatment with perphenazine in psychiatry].
    Ropert R
    Psychopharmacologie; 1971; ():71-82. PubMed ID: 5162009
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.